Source: Cancer Genetics. Unidades: FMRP, IB, ICB, FM
Subjects: LEUCEMIA MIELOIDE, LIPÍDEOS, CITOGENÉTICA, PROTEÍNAS QUINASES, LIPÍDEOS, TRANSCRIÇÃO GÊNICA, MICRORNAS, EXPRESSÃO GÊNICA, RNA, GENÔMICA
ABNT
LIMA, Keli Cristina de et al. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia. Cancer Genetics, v. 233-234, p. 56-66, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.cancergen.2019.04.002. Acesso em: 16 nov. 2024.APA
Lima, K. C. de, Silva, J. L. C. da, Kinker, G. S., Pereira-Martins, D. A., Traina, F., Fernandes, P. A. C. M., et al. (2019). PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia. Cancer Genetics, 233-234, 56-66. doi:10.1016/j.cancergen.2019.04.002NLM
Lima KC de, Silva JLC da, Kinker GS, Pereira-Martins DA, Traina F, Fernandes PACM, Markus RP, Lucena-Araújo ARL, Machado Neto JA. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia [Internet]. Cancer Genetics. 2019 ; 233-234 56-66.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.cancergen.2019.04.002Vancouver
Lima KC de, Silva JLC da, Kinker GS, Pereira-Martins DA, Traina F, Fernandes PACM, Markus RP, Lucena-Araújo ARL, Machado Neto JA. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia [Internet]. Cancer Genetics. 2019 ; 233-234 56-66.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.cancergen.2019.04.002